Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Medicine (3)
Signal Transduction and Targeted Therapy (1)
The ISME Journal (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

Research (5)

Subject Check one or more subjects to show results from those subjects only.

Biomarkers
Cancer
Diseases
Genetics
Medical research
Microbiology
Oncology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–5 of 5 results

Advanced filters: Author: Hai-Yan Tu Clear advanced filters

Cerebrospinal fluid circulating tumor DNA profiling for risk stratification and matched treatment of central nervous system metastases

Cerebrospinal fluid circulating tumor DNA profiling had prognostic value in a cohort of 584 patients with lung cancer and central nervous system metastases, and could be used to inform personalized therapies.

Mei-Mei Zheng
Qing Zhou
Yi-Long Wu
Research27 Feb 2025
Nature Medicine

Volume: 31, P: 1547-1556
First-line pyrotinib in advanced HER2-mutant non-small-cell lung cancer: a patient-centric phase 2 trial

Treatment of patients with HER2-mutant non-small-cell lung cancer with the pan-HER inhibitor pyrotinib in a phase 2 trial or compassionate use showed a favorable objective response rate, whereas patients treated in parallel by physician’s choice in a real-world study did not.

Si-Yang Maggie Liu
Hai-Yan Tu
Yi-Long Wu
Research24 Jul 2023
Nature Medicine

Volume: 29, P: 2079-2086
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

In a prospective international cohort of 1,127 patients with non-small-cell lung cancer and ctDNA-guided therapy, ctDNA detection was associated with shorter survival, independently of clinicopathologic features and metabolic tumor volume.

Justin Jee
Emily S. Lebow
Bob T. Li
Research10 Nov 2022
Nature Medicine

Volume: 28, P: 2353-2363
Stainless steel corrosion via direct iron-to-microbe electron transfer by Geobacter species

Hai-Yan Tang
Chuntian Yang
Derek R. Lovley
Research10 May 2021
The ISME Journal

Volume: 15, P: 3084-3093
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study

Si-Yang Liu
Song Dong
Yi-Long Wu
ResearchOpen Access06 Dec 2023
Signal Transduction and Targeted Therapy

Volume: 8, P: 1-10